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Bartonella bacilliformis is the causative agent of Carrion’s disease, this illness affects poor communities of
Andean valleys (Peru, Colombia and Ecuador) [1]. B. bacilliformis produces a biphasic infection: acute phase
presents severe anemia and immunosuppression, and chronic phase involves dermal eruption [1]. Currently, the
available tools for the diagnosis of Carrion’s disease include low sensitive serological assays and expensive
molecular tools [2]. To improve the diagnosis, this project aims to produce monoclonal antibodies specific
soluble proteins of B. bacilliformis. The monoclonal antibodies production was performed immunizing three
Balb/C mice with soluble proteins obtained from the total lysate of B. bacilliformis. The immune response was
tested by ELISA at a serum dilution of 1:500 and 1:8000, seropositive animals were sacrificed to obtain B
lymphocytes from the spleen. The B lymphocytes were fused with Ag8 myeloma cells in HAT medium, the
obtained hybridomas were cloned. ELISA evaluation was performed for the selection of the monoclonalantibody producing clones. The optical densities and antibody titers were analyzed using the statistical package
SPSS. 21. The sera titer of immunized mice was equivalent to 0.8-1.0 OD at 1:8000 dilution, whilst the OD of
the medium of the hybridomas was 0.2-2.0 (FIG. 1). Clones displaying higher density were growth upon reach
OD of 2.0. Monoclonal antibodies were successfully produced, but antibody identification is pending evaluation.

Figure 1 - IgM and IgG titers after second immunization of mice with soluble proteins of B. bacilliformis
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